Health House is carrying out a study on its own-branded cannabis extracts.
Piauhy Labs will study the efficacy of cannabinoids for the treatment of diseases such as autism, epilepsy and Alzheimer’s.
Linneo Health has had its GMP certification renewed for its quality control laboratory and its post-harvest facility.
DiArcangelo entered into medical cannabis following a personal experience with a loved one.
In this article, Christopher Tasker, CEO of Global Cannabinoid Solutions, discusses how science can help your cannabis business.
The development will give hope to cancer patients as current treatment options for cancer-related pain are largely ineffective.
BioHarvest Sciences says the groundbreaking structure is instrumental in the ability to grow trichome cells in bioreactors at scale.
Cleaver Leaves has announced it will be supporting The University of Missouri by providing CBD isolate at no cost. Clever
The compound was selected based on a wide-ranging screen of derivatives of CBD and CBG made by cannabis pioneer Professor Mechoulam.
MGC Pharma is hoping to bring more surprises to the market in the next few years.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
